CRAMS INDUSTRY OVERVIEW
· CRAMS INDUSTRY BUSINESS MODEL
· DRUG DISCOVERY PROCESS
· CRAMS REVENUE MODEL
· INDUSTRY TAILWINDS
· INDUSTRY HEADWINDS
· SUMMARY
· RATINGS
COMPANY OVERVIEW
· MILESTONES
· SYNGENE CORPORATE STRUCTURE
· SYNGENE REVENUE MODEL
· GEOGRAPHICAL REVENUE 2018 VERSUS 2021
· DEDICATED R&D CENTRES
· SEGMENT REVENUE TREND
· CLIENT BASE OVER THE YEARS
· CLIENT BASE ACROSS INDUSTRIES
· FORAYING INTO BIOLOGICS
· GLOBAL PEERS LONZA & WUXI APPTEC VERSUS SYNGENE
· SUMMARY
· RATINGS
CORPORATE GOVERNANCE
· SHAREHOLDING PATTERN
· TOP MANAGEMENT
· PROMOTER INFORMATION
· INSTITUTIONAL HOLDING INFORMATION
· EMPLOYEE RATINGS
· FORENSIC ACCOUNTING ANALYSIS
· SUMMARY
· RATINGS
FINANCIALS
· QUARTERLY PERFORMANCE- GROSS SALES
· QUARTERLY CONSOLIDATED OPERATING & NET PROFIT(CRORES)
· QUARTERLY PERFORMANCE
· ANNUAL PERFORMANCES- GROSS SALES
· ANNUAL OPERATING PROFITS TREND
· ANNUAL PERFORMANCES- NET PROFIT TREND
· ANNUAL PERFORMANCES- OPERATING PROFIT & NET PROFIT MARGINS TREND
· ANNUAL PERFORMANCES- CASH FROM OPERATING & INVESTING ACTIVITIES TREND
· DEBT TO EQUITY RATIO & INTEREST COVERAGE RATIO TREND
· RETURN ON ASSET & ASSET TURNOVER TREND
· ROCE & ROE TREND
· CASH CONVERSION CYCLE TREND
· CASH FLOW FROM OPERATIONS NET CAPEX & FREE CASH FLOW OVER THE YEARS(CRORES)
· EMPLOYEE COST: THE MAJOR COST OF THE COMPANY (CRORES)
· CAPEX, DEPRECIATION & WORK IN PROGRESS (CRORES)
· GLOBAL PEERS LONZA & WUXI APPTECH VERSUS SYNGENE
· PEER COMPARISON
· SUMMARY
· RATINGS
VALUATIONS
· SHARE PERFORMANCE
· PE RATIO & PB TREND
· EV/EBITDA TREND
· VALUATION RATIOS- PEERS
· RATING
· PORTERS FIVE FORCES ANALYSIS
DATA SOURCE
DISCLAIMER
ABOUT US
STOCK SUBSCRIPTION PRODUCT
OUR PRODUCTS & SERVICES
CONTACT US